Price $125.83 |
Market Cap
249.33B
|
Sector Health Care |
Div. Growth
22.10%
|
|
P/E
34.7
|
P/B
7.26
|
P/S
5.9
|
Dividend %
1.30%
|
|
P/CF
52.3
|
P/FCF
40.2
|
Op. Cash Flow
11.26M
|
FCF
3.5
|
|
Op. Margin
20.10%
|
Net Margin
17.10%
|
ROE
21.50%
|
ROI
9.70%
|
|
ROA
9.90%
|
EPS Growth
113.60%
|
Current Ratio
1.7
|
Debt/Equity
56.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Viatris Inc (VTRS) | $14.53 | - | 3.30% | 16.39B | Strong Buy |
| Biomerica, Inc. (BMRA) | $4.37 | - | - | 48.8M | Strong Buy |
| Endo International PLC (ENDP) | $3.21 | - | - | 923M | Strong Buy |
| Puma Biotechnology Inc (PBYI) | $2.40 | - | - | 130M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $63.54 | - | 3.50% | 138.77B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
